Astrivax Therapeutics

Astrivax Therapeutics is a clinical stage biopharmaceutical company focused on developing DNA-based immunotherapies through a novel technology platform. The company aims to address challenging diseases, primarily focusing on treating Hepatitis B, Human Papilloma virus, and other emerging viral infectious diseases using its patented plasmid-based Launch-iT technology, which enables the rapid development of immunotherapies and vaccines.